UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053892
Receipt number R000061466
Scientific Title Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota
Date of disclosure of the study information 2025/04/01
Last modified on 2025/09/17 12:59:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota

Acronym

Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota

Scientific Title

Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota

Scientific Title:Acronym

Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the impact of foods containing probiotics from a person's gut microbiota on that their gut microbiota

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relative abundance of Bifidobacterium

Key secondary outcomes

Gut microbiota analysis
Subjective evaluation questionnaire on depression, activity levels, and sleep quality


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake test food for 1week > follow up for 3 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1. Male and female participants aged 20 to under 60 years at the time of consent acquisition.
2. Individuals who have received sufficient explanation about the trial, can understand its content, and from whom consent has been obtained personally.

Key exclusion criteria

1. Individuals who regularly use specific health foods, functional foods, health supplements, supplements, probiotics, etc., more than three times a week, which could potentially affect the trial, and cannot discontinue them from the time of consent acquisition.
2. Individuals who have taken medications (e.g., antibiotics, intestinal regulators, laxatives, etc.) that may potentially affect the trial within 3 months prior to consent acquisition.
3. Individuals deemed unsuitable as trial subjects based on the responses to the background survey in the preliminary investigation.
4. Heavy alcohol drinkers.
5. Individuals with a history or current presence of serious diseases of the heart, liver, kidneys, digestive system, etc.
6. Pregnant, breastfeeding, or individuals intending to become pregnant during the trial period.
7. Individuals with allergies to medications or food.
8. Individuals participating in other clinical trials for drugs or health foods, within 4 weeks after the end of such trials, or planning to participate in another clinical trial after consenting to participate in this trial.
9. Individuals whom the trial investigator deems inappropriate for participation in the study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Natsuki
Middle name
Last name Suganuma

Organization

bacterico

Division name

Research and Development Department

Zip code

530-0027

Address

7th Floor, Sankyo Umeda Building, 1-5 Douyamacho, Kita-ku, Osaka City, Osaka Prefecture

TEL

06-4397-3516

Email

info@bacterico.co.jp


Public contact

Name of contact person

1st name Natsuki
Middle name
Last name Suganuma

Organization

bacterico

Division name

Research and Development Department

Zip code

530-0027

Address

7th Floor, Sankyo Umeda Building, 1-5 Douyamacho, Kita-ku, Osaka City, Osaka Prefecture

TEL

06-4397-3516

Homepage URL


Email

info@bacterico.co.jp


Sponsor or person

Institute

Bacterico

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiyoda Paramedical Care Clinic Ethics Committee

Address

2nd Floor, Daiwa Building, 3-3-10 Nihonbashi Honcho, Chuo-ku, Tokyo

Tel

03-6225-9005

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 11 Month 28 Day

Date of IRB

2023 Year 12 Month 03 Day

Anticipated trial start date

2024 Year 01 Month 31 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 03 Month 18 Day

Last modified on

2025 Year 09 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061466